The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
213 S. Wheaton Ave.
Wheaton, IL 60187 USA
6305101115
6305108508
8009426825
The Neurofibromatosis, Inc., is a national, voluntary, non-profit organization dedicated to providing information, support, and advocacy to individuals and family members affected by neurofibromatosis type I (NF1) and type II (NF2). NF1 is a genetic disorder characterized by the development of multiple benign tumors on the covering of nerve fibers and the appearance of brown spots and freckles on the skin. NF2 is a rare genetic disorder characterized by the development of benign tumors on both auditory nerves and in other areas of the body. Established in 1988, Neurofibromatosis, Inc., services the needs of affected individuals through coordinated educational, support, and clinical and research programs. The organization provides information about NF1 and NF2 to affected individuals, family members, healthcare and other professionals, and the general public; provides referrals to local medical resources; and assists in identifying community support services. Neurofibromatosis, Inc., also encourages and supports research.
Please Note
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.
